Filing Details
- Accession Number:
- 0001213900-22-050239
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-22 21:59:43
- Reporting Period:
- 2022-08-18
- Accepted Time:
- 2022-08-22 21:59:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1782107 | Blue Water Vaccines Inc. | BWV | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1895467 | Erin Henderson | C/O Blue Water Vaccines Inc. 201 E. Fifth Street, Suite 1900 Cincinnati OH 45202 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-08-18 | 24,752 | $0.01 | 24,752 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2022-08-19 | 4,834 | $0.01 | 29,586 | No | 4 | F | Direct | |
Common Stock | Disposition | 2022-08-19 | 4,834 | $3.97 | 24,752 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Disposition | 2022-08-18 | 24,810 | $0.01 | 24,810 | $0.01 |
Common Stock | Stock Option | Disposition | 2022-08-19 | 4,834 | $0.01 | 4,834 | $0.01 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
21,110 | 2021-04-02 | 2030-04-02 | No | 4 | F | Direct |
16,276 | 2021-04-02 | 2030-04-02 | No | 4 | F | Direct |
Footnotes
- The Common Stock reported herein were sold by the reporting person at a high price of $4.00, a low price of $3.96 and an average price of $3.97 per share of Common Stock. Upon request, the reporting person will provide details of each sale.